Urinary Bladder, Overactive: all 864 studies
Page 7 of 9. Open to participants first (125), then studies with results posted, then the rest; newest registration first within each.
- Treatment of REfractory Overactive BLadder With the AXonics Sacral Neuromodulation System (RELAX-OAB)CompletedNCT02620410Not applicable
- Clinical Trial of Sacral Neuromodulation for Treatment of Refractory Overactive Bladder (OAB)Status unknownNCT02619721Early Phase 1
- Extension Study of Fesoterodine for Overactive Bladder Syndrome in Children.CompletedNCT02614482Phase 3
- A Safety and Efficacy Study of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in Korean PatientsCompletedNCT02601287Phase 4
- A Safety and Efficacy Study of BOTOX® (Botulinum Toxin Type A) in Patients With Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in IndiaCompletedNCT02590250
- Neurogenic Overactive Bladder Treatment on Parkinson's Disease Through Back Tibial Nerve ElectrostimulationStatus unknownNCT02583529Early Phase 1
- Specified Drug Use-results Survey of Betanis Tablets for Patients With Coexisting Cardiovascular DiseaseCompletedNCT02570035
- Acupuncture on Post-Stroke Overactive BladderCompletedNCT02568774Not applicable
- Urinary Retention Rates in Clinical Practice After Treatment With OnabotulinumtoxinA for Idiopathic Overactive BladderCompletedNCT02557971
- Do Patient Anxiety Levels Decrease Urodynamic Test Reproducibility?CompletedNCT02540798
- Comparisons of the Effects of Solifenacin Versus Mirabegron on Autonomic System, Arterial Stiffness and Psychosomatic Distress and Clinical OutcomesCompletedNCT02540707Phase 4
- A Study of the Effect of Antibiotics on the Microbiology of the Bladder in Patients With Overactive BladderCompletedNCT02536872
- A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron Oral Suspension in Pediatric Subjects From 3 to Less Than 12 Years of Age With Neurogenic Detrusor Overactivity (NDO) or Overactive Bladder (OAB)CompletedNCT02526979Phase 1
- Use of Biotene Moisturizing Mouth Spray for Xerostomia Associated With Oral Oxybutynin UseWithdrawnNCT02522936Phase 4
- Overactive Bladder EducationTerminatedNCT02505607Not applicable
- The Effect of an Additional Stress Incontinence Procedure on Overactive Bladder During Pelvic Organ Prolapse RepairCompletedNCT02502838
- The PK Study of the JLP-1207 and Solifenacin/Tamsulosin in Healthy Male Volunteers.CompletedNCT02494349Phase 1
- Clinical Study to Assess the Efficacy and Safety of THVD-201 in Patients With OABCompletedNCT02485067Phase 3
- Brain Areas Involved in Bladder Filling and ContractionStatus unknownNCT02477241Not applicable
- Prospective Study for Patient Perception of Treatment Satisfaction After Switching to Mirabegron in Patients With Overactive Bladder Who Were Unsatisfied With Efficacy of Antimuscarinic Therapy or Adverse Event.CompletedNCT02468375Phase 4
- Effects of TENS in Autonomous System in Women With Overactive BladderStatus unknownNCT02456441Not applicable
- Treatment, Parallel Assignment, Double Blind (Subject, Outcomes Assessor), Efficacy StudyStatus unknownNCT02452879Not applicable
- Randomized Trial of Tibial Nerve Stimulation Versus Pelvic Floor Exercises for Treatment of Overactive BladderStatus unknownNCT02452593Not applicable
- Investigate the Effect of Food on the Pharmacokinetic of JLP-1207 in Healthy Male VolunteersCompletedNCT02447367Phase 1
- Cystoscopic Ablation Via RF Energy Clinical TrialTerminatedNCT02398578Phase 1/2
- Urinary Neurotrophin Levels in Healthy ChildrenStatus unknownNCT02389270
- A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB)CompletedNCT02386072
- Fesoterodine on Urgency Episodes in Parkinson's Disease PopulationTerminatedNCT02385500Phase 4
- Use of Transcutaneous Posterior Tibial Nerve Stimulation (TPTNS) in Maintaining OAB Symptoms Improvement.CompletedNCT02377765Not applicable
- MIrabegron With oveRACtive bLadder Symptoms in mEnStatus unknownNCT02361502Phase 4
- Association Between Metabolic Syndrome and Serum Nerve Growth Factor Levels in Women With Overactive BladderStatus unknownNCT02335853
- Fesoterodine and Oxybutynin XL for Overactive Bladder Syndrome in ChildrenCompletedNCT02327936Phase 3
- A Prospective Non-interventional Study in Overactive Bladder (OAB) Patients Prescribed Betmiga® as Part of Routine Clinical PracticeCompletedNCT02320773
- Foot Neuromodulation for Overactive Bladder in ChildrenWithdrawnNCT02320201Not applicable
- BlueWind Medical System for the Treatment of Patients With OABCompletedNCT02299544Not applicable
- Botox for Neurogenic Detrusor Overactivity and the Prevention of Autonomic Dysreflexia Following SCICompletedNCT02298660Phase 4
- A Follow-net Investigation of a Randomised Study of Cystoscopy and Urethral Dilatation Versus Cystoscopy Alone in Women With Overactive Bladder Syndrome and Impaired VoidingWithdrawnNCT02297178
- Efficacy And Safety Of Combination Therapy For Treatment Of Overactive Bladder In Male Patients With Benign Prostatic Hyperplasia.Status unknownNCT02279615Phase 4
- The Effect and Safety of Moxibustion Therapy for Overactive Bladder PatientsCompletedNCT02271607Not applicable
- Virtual Avatar Coaches for Behavioral Therapy of Patients With Overactive BladderCompletedNCT02251054Not applicable
- A Study of Fesoterodine and Oxybutynin on Cognitive Function in Mild Cognitive ImpairmentCompletedNCT02240459Phase 2
- A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron OCAS (Oral Controlled Absorption System) in Pediatric Subjects With Neurogenic Detrusor Overactivity or Overactive BladderCompletedNCT02211846Phase 1
- Educating Patients on Management of Overactive Bladder: Written Versus Verbal InstructionsCompletedNCT02197533Not applicable
- Sacral Neuromodulation With InterStim® Therapy for Intractable Urinary Voiding Dysfunctions (SOUNDS): an Observational StudyCompletedNCT02186041
- Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Solifenacin and TamsulosinCompletedNCT02180997Phase 1
- "The Effects of Caffeine on Overactive Bladder Symptoms and Mental Health in Postmenopausal Women"CompletedNCT02180048Not applicable
- Safety and Efficacy of Intravesical Botulinum Toxin in TC-3 Gel in OAB PatientsTerminatedNCT02179099Phase 1/2
- An Observational Study of BOTOX® for the Management of Urinary Incontinence in Patients With Idiopathic Overactive BladderCompletedNCT02161159
- Efficacy of Darifenacin and Physiotherapy for the Treatment of Overactive Bladder in WomenCompletedNCT02143570Phase 3
- Is the Nerve Growth Factor (NGF) a Useful Biomarker in Neurogenic Bladder Dysfunction After Spinal Cord Injury?CompletedNCT02138149
- Injections of Botulinum Toxin A in Treatment of Patients With Detrusor Overactivity and Impaired ContractilityCompletedNCT02135341Phase 2
- Bryophyllum Pinnatum Versus Solifenacin Versus Placebo for Overactive BladderTerminatedNCT02129816Phase 2/3
- Neuromodulation Implantation Settings Variation for Overactive BladderWithdrawnNCT02112786Not applicable
- Efficacy of Transcutaneous Nerve Stimulation on Improvement of Overactive Bladder SymptomsWithdrawnNCT02110680Phase 2
- Does Bladder Training Improve the Efficacy of Nerve Stimulation in Women With Refractory Overactive BladdersCompletedNCT02107820Not applicable
- A Study to Evaluate Quality of Life in Patients Switched to Solifenacin From Other AntimuscarinicsCompletedNCT02087098
- Gene Expression in the Overactive Bladder in ChildrenStatus unknownNCT02086058
- Oxybutynin and Omega-3 for OAB (Overactive Bladder)TerminatedNCT02070042Not applicable
- Development of Novel Cystometrics for Overactive BladderWithdrawnNCT02060214
- Time of Effect Onset in Treating Overactive Bladder or Non Obstructive Urinary Retention by Sacral NeuromodulationCompletedNCT02040519Not applicable
- Efficacy, Tolerability and Impact on Quality of Life of Propiverine in Patients With Overactive Bladder SyndromeCompletedNCT02024945
- Evaluation of Safety and Efficacy of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in KoreaCompletedNCT02010788
- Botulinum Toxin in the Treatment of Idiopathic Detrusor OveractivityStatus unknownNCT02009540Phase 4
- Cystoscopy and Cystodistension; Therapeutic and Aetiological Aspect in Overactive BladderCompletedNCT01971437Not applicable
- Secondary Bilateral Sacral Nerve Stimulation in Overactive Bladder PatientsCompletedNCT01960270Not applicable
- Severity of Overactive Bladder Symptoms in Patients After Synergo TreatmentCompletedNCT01955408
- Electrical Nerve Stimulation for Overactive Bladder a Comparison of TreatmentsStatus unknownNCT01940367Not applicable
- Clinical and Biochemical Evidence of Neurogenic Inflammation in Women With Urinary UrgencyCompletedNCT01933074
- Validation of Instruments for Pragmatic Clinical Trials for Overactive BladderCompletedNCT01925456Phase 1
- Drug Use-Results Survey of Betanis Tablets in JapanCompletedNCT01919047
- Comparison of Posterior Tibial Nerve Electrical Stimulation Protocols for Overactive Bladder SyndromeCompletedNCT01912885Not applicable
- Long-Term Specified Drug Use-results Survey of Betanis TabletsCompletedNCT01901120
- Specified Drug Use-results Survey of Betanis TabletsCompletedNCT01898624
- Correlations of 3D Urethral and Paraurethral Sonographic Findings With Urodynamic Studies, Lower Urinary Tract Symptoms & Sexual Dysfunction in Female Patients With Lower Urinary Tract Symptoms.CompletedNCT01884753
- Comparisons of 3-month Versus 6-month Solifenacin Treatment for Female OAB PatientsStatus unknownNCT01876186Phase 4
- Phase 1 Study With OAB Assessing the Safety and Activity of hMaxi-K Gene TransferCompletedNCT01870037Phase 1
- Study Evaluating the Safety, Tolerability, and Efficacy of Dexmecamylamine (TC-5214) for Treatment of Overactive BladderCompletedNCT01868516Phase 2
- UNGF Assessment in Patients With Detrusor Overactivity Undergoing Sacral NeuromodulationCompletedNCT01850706
- Bladder Thermal Distention for Patients With Refractory Overactive BladderStatus unknownNCT01842685Not applicable
- Effectiveness and Safety Study of Solifenacin Succinate and Solifenacin Succinate + Estrogen to Treat OAB in Postmenopausal WomenCompletedNCT01833663Phase 4
- Flexibly adding-on Second Antimuscarinic Agent to the First Antimuscarinics for Refractory Overactive Bladder SyndromeCompletedNCT01824420Phase 4
- Antimuscarinic Treatment for Female Patients With Overactive Bladder Syndrome: Comparison of Daytime and Nighttime DosingCompletedNCT01819168
- Treatment of Symptoms in Male Patients With Lower Urinary Tract Symptoms (LUTS) Predominant Storage Symptoms (Overactive Bladder Syndrome)CompletedNCT01799902
- Peripheral Electrical Stimulation for the Treatment of Overactive BladderCompletedNCT01783392Not applicable
- Prognostic Value of the Urinary Nerve Growth Factor in the Patients With Benign Prostatic HyperplasiaCompletedNCT01781117Not applicable
- Supraspinal Control of Lower Urinary Tract Function in Healthy Controls and Patients With Bladder DysfunctionCompletedNCT01768910Not applicable
- Use of Percutaneous Tibial Nerve Stimulation With Solifenacin or Placebo to Treat Refractory Overactive BladderTerminatedNCT01764893Phase 4
- Physical Therapy for Overactive BladderTerminatedNCT01758848
- Management of the Idiopathic Overactive Bladder With Botulinum Toxin: Systematic ReviewStatus unknownNCT01750645
- Post Marketing Study to Evaluate the Efficacy and Safety of Solifenacin in Patients With OAB (Overactive Bladder) After TURP (Trans-urethral Resection of Prostate) or PVP (Photoselective Vaporization of Prostate)CompletedNCT01747577Phase 4
- Urinary Biomarkers For Objective Measurement Of InterStim® Response In Over Active Bladder (OAB) Patients.CompletedNCT01739946
- Microbiomes of Pelvic PainCompletedNCT01738464
- Prevention of Bladder Dysfunction in Acute Spinal Cord InjuryCompletedNCT01698138Phase 4
- Lessening Incontinence by Learning YogaCompletedNCT01672190Not applicable
- Pain-perception During Outpatient cystoscopy-a Prospective Controlled StudyCompletedNCT01663181
- A Study of Effects of Fesoterodine in Men at High Risk for Overactive Bladder/Detrusor Overactivity Post Robotic-Assisted Lap. ProstatectomyCompletedNCT01661166Phase 4
- The Long-term Efficacy of Electrical Pudendal Nerve Stimulation for the Urgency-Frequency Syndrome in WomenCompletedNCT01659216
- Different Injection Number of the Same Dose of Botulinum Toxin A on Overactive Bladder SyndromeCompletedNCT01657409Phase 2
- Urgent-SQ in Treatment of Overactive Bladder Syndrome: 9-yr Follow upCompletedNCT01644409
- A Randomized, Placebo-Controlled Study to Assess the Efficacy of Propantheline for the Treatment of Overactive BladderStatus unknownNCT01640002Phase 1